Northeast Asia

China’s Suning Financial Services, a subsidiary of home appliance company Suning Holding Group, is tapping the offshore loan market with a $300m borrowing.

In this round-up, the trade negotiation between China and the US finished its tenth round, China PMI fell in April after previously rebounding and the chairman of the banking and insurance regulator promised more reform.

China’s Zai Lab has priced a follow-on sale of 7.8m American Depository Share (ADS), its second since its listing on the Nasdaq.

Viva Biotech Holdings has pulled off an impressive HK$1.52bn ($194m) Hong Kong IPO, striking retail gold as the local public swamped the deal, grabbing half of the stock for themselves. The high level of retail interest is a rarity for IPOs in the city and something that is often unwanted, bringing potential wild price swings to a stock soon after listing, say some bankers. But others foresee enough institutional demand to swallow any bulk selling in the first days of trading. Jonathan Breen reports.

Although the Shanghai Stock Exchange (SSE) has received 98 applications from companies hoping to launch an IPO on its new tech board, a lengthy and complicated approval process has revealed some of the problems facing potential listing candidates. Meanwhile, there are doubts over some of the investors preparing to buy into the market. Rebecca Feng reports.

Duiba Group raised $667m after concluding its second attempt at listing on the Hong Kong Stock Exchange.

The Tianjin government’s waning support for local corporations was brought into focus this week, when Fitch downgraded Chinese dollar bond issuer Tewoo Group by a hefty six notches. It was the latest warning sign of the debt-servicing ability of the city’s struggling state-owned enterprises (SOEs). Addison Gong reports.

I remember a time when dressing in casual clothes was something that horrified bankers, not excited them. Not anymore.

Software company Kingsoft Corp plans to spin off and list Beijing Office Software on Shanghai’s new technology board, pulling its initial plan to float the subsidiary on the Shenzhen Stock Exchange’s junior ChiNext board.

China’s Yingde Gases Group has received a strong response in the loan market for its $300m three year facility.

Components manufacturer Impro Precision Industries this week began its third attempt to float on the Hong Kong Stock Exchange.

A year ago, Hong Kong’s stock exchange (HKEX) added a new chapter to its regulations, allowing pre-revenue biotechnology companies to list. The historic move has turned the city into the biotech IPO hub of Asia. But its fortune could change if the Mainland’s new Nasdaq-style Shanghai tech board, which offers similar pre-revenue concessions, stems the flow of its primarily Chinese issuers.